Evidence map›Paper›PMID 32626643›Full record

ArticleChemistryOpen2020

Synthesis of Core-Shell Magnetic Supramolecular Nanocatalysts based on Amino-Functionalized Calix[4]arenes for the Synthesis of

Reza Eivazzadeh-Keihan, Ehsan Bahojb Noruzi, Fateme Radinekiyan, Milad Salimi Bani, Ali Maleki, Behrouz Shaabani, Mohammad Haghpanahi

Open access · goldAbstract read
In one paragraph

Article in ChemistryOpen, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
1.7field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 24 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Synthesis of FeScientific reports · 2023
    Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Reza Eivazzadeh-KeihanCatalysts and Organic Synthesis Research Laboratory, Department of Chemistry Iran University of Science and Technology Tehran 16846-13114 Iran.
Ehsan Bahojb NoruziFaculty of Chemistry, Department of Inorganic Chemistry University of Tabriz Tabriz Iran.
Fateme RadinekiyanCatalysts and Organic Synthesis Research Laboratory, Department of Chemistry Iran University of Science and Technology Tehran 16846-13114 Iran.
Milad Salimi BaniSchool of Mechanical Engineering Iran University of Science and Technology Tehran Iran.
Ali MalekiCatalysts and Organic Synthesis Research Laboratory, Department of Chemistry Iran University of Science and Technology Tehran 16846-13114 Iran.ORCID 0000-0001-5490-3350
Behrouz ShaabaniFaculty of Chemistry, Department of Inorganic Chemistry University of Tabriz Tabriz Iran.
Mohammad HaghpanahiSchool of Mechanical Engineering Iran University of Science and Technology Tehran Iran.
Iran University of Science and Technology · IRUniversity of Tabriz · IR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

One of the most common phenol-formaldehyde cyclic oligomers from hydroxyalkylation reactions that exhibit supramolecular chemistry are calixarenes. These macrocyclic compounds are qualified to act as synthetic catalysts due to their specific features including being able to form host-guest complexes, having unique structural scaffolds and their relative ease of chemical modifications with a variety of functions on their upper rim and lower rim. Here, a functional magnetic nanocatalyst was designed and synthesized by using a synthetic amino-functionalized calix[4]arene. Its catalytic activity was evaluated in a one-pot synthesis of 2-amino-

Indexed as

2-amino-4H-chromenecalixarenesheterogeneous catalysissonochemistrysupramolecular chemistry

Identifiers

PMID32626643
PMCPMC7327476
OpenAlexW3013029382

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.